Overview

Conversion of Seddon III Nerve Injury to Seddon I/II Nerve Injury

Status:
Recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of PEG 3350 for use in nerve repair.
Phase:
Phase 1
Details
Lead Sponsor:
WellSpan Health
Collaborator:
Neuraptive Therapeutics Inc.